Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Prepaid Assets: 2014-2025

Historic Prepaid Assets for Viking Therapeutics (VKTX) over the last 11 years, with Sep 2025 value amounting to $2.2 million.

  • Viking Therapeutics' Prepaid Assets rose 29.37% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 29.37%. This contributed to the annual value of $1.1 million for FY2024, which is 55.27% down from last year.
  • Per Viking Therapeutics' latest filing, its Prepaid Assets stood at $2.2 million for Q3 2025, which was down 20.36% from $2.8 million recorded in Q2 2025.
  • Viking Therapeutics' 5-year Prepaid Assets high stood at $3.9 million for Q1 2023, and its period low was $138,000 during Q2 2024.
  • Moreover, its 3-year median value for Prepaid Assets was $1.1 million (2024), whereas its average is $1.6 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 85.62% in 2024, then spiked by 1,939.86% in 2025.
  • Quarterly analysis of 5 years shows Viking Therapeutics' Prepaid Assets stood at $619,000 in 2021, then surged by 451.05% to $3.4 million in 2022, then decreased by 26.06% to $2.5 million in 2023, then slumped by 55.27% to $1.1 million in 2024, then rose by 29.37% to $2.2 million in 2025.
  • Its Prepaid Assets stands at $2.2 million for Q3 2025, versus $2.8 million for Q2 2025 and $865,000 for Q1 2025.